Literature DB >> 14688211

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.

Eun-Joung Moon1, Chul-Ho Jeong, Joo-Won Jeong, Kwang Rok Kim, Dae-Yeul Yu, Seishi Murakami, Chul Woo Kim, Kyu-Won Kim.   

Abstract

Hepatitis B virus X protein (HBx) is closely involved in the development of hepatocellular carcinoma, a highly vascularized solid tumor. Here we show that HBx increases the transcriptional activity and protein level of hypoxia-inducible factor-1alpha (HIF-1alpha) under both normoxic and hypoxic conditions, and it also stimulates angiogenesis. HBx directly interacted with the bHLH/PAS domain of HIF-1alpha but not with the von Hippel-Lindau protein (pVHL). HBx decreased the binding of pVHL to HIF-1alpha and prevented ubiquitin-dependent degradation of HIF-1alpha. In HBx-transgenic mice, HIF-1alpha and vascular endothelial growth factor were strongly detected in the dysplastic lesion, where HBx was also more highly expressed than in the non-neoplastic region of the liver. An immunohistochemical study showed that microvessels are more abundant in the dysplastic lesion than in the non-neoplastic region. Our data suggest that HBx stabilizes HIF-1alpha and leads to angiogenesis during hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688211     DOI: 10.1096/fj.03-0153fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein.

Authors:  Yoon Kyung Choi; Chun-Ki Kim; Hansoo Lee; Dooil Jeoung; Kwon-Soo Ha; Young-Guen Kwon; Kyu-Won Kim; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

3.  p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.

Authors:  Lingling Xian; Jing Zhao; Jia Wang; Zhou Fang; Bo Peng; Wenzhang Wang; Xiaona Ji; Long Yu
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

4.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

5.  Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.

Authors:  Mariko Tomita; Gregg L Semenza; Canine Michiels; Takehiro Matsuda; Jun-Nosuke Uchihara; Taeko Okudaira; Yuetsu Tanaka; Naoya Taira; Kazuiku Ohshiro; Naoki Mori
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

6.  Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma.

Authors:  Ying-Ying Lee; Myth T S Mok; Alfred Sze-Lok Cheng
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

Review 7.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.

Authors:  T M Bui-Nguyen; S B Pakala; R D Sirigiri; W Xia; M-C Hung; S K Sarin; V Kumar; B L Slagle; R Kumar
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867

9.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 10.  Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.

Authors:  De-Cai Yu; Jun Chen; Yi-Tao Ding
Journal:  Int J Mol Sci       Date:  2010-08-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.